(19)
(11) EP 0 975 627 A1

(12)

(43) Date of publication:
02.02.2000 Bulletin 2000/05

(21) Application number: 98910927.7

(22) Date of filing: 09.04.1998
(51) International Patent Classification (IPC)7C07D 403/12, A61K 31/415
(86) International application number:
PCT/IB9800/540
(87) International publication number:
WO 9846/595 (22.10.1998 Gazette 1998/42)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 15.04.1997 US 42316 P

(71) Applicant: THE PROCTER & GAMBLE COMPANY
Cincinnati,Ohio 45202 (US)

(72) Inventors:
  • CUPPS, Thomas, Lee
    Norwich, NY 13815 (US)
  • BOGDAN, Sophie, Eva
    Maineville, OH 45039 (US)
  • MIELING, Glen, Edward
    West Chester, OH 45069 (US)
  • NIKOLAIDES, Nick
    Mason, OH 45040 (US)
  • HENRY, Raymond, Todd
    Pleasant Plain, OH 45162 (US)
  • SHELDON, Russell, James
    Fairfield, OH 45014 (US)

(74) Representative: Woof, Victoria et al
Procter & GambleTechnical Centers Limited,Lovett House,Lovett Road
Staines, Middlesex TW18 3AZ
Staines, Middlesex TW18 3AZ (GB)

   


(54) 5-(2-IMIDAZOLINYLAMINO)BENZIMIDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS